On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On May 2, 2020, Roche announced that the FDA has issued an Emergency Use Authorization for its new…
On May 1, 2020, Gilead announced the FDA granted emergency use authorization (EUA) for the investigational antiviral remdesivir…
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On May 1, 2020, Janssen Pharma, a Johnson & Johnson company, announced the U.S. Food and Drug Administration…
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) received notice that its SARS-CoV-2 qPCR Kit had complied with…
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics hasd entered into a…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valnevaï¾’s Lyme disease vaccine…
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements,…
On Apr. 30, 2020, Mateon Therapeutics reported several peer-reviewed publications derived from its R&D effort against COVID-19. Published…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…